SMMT
HEALTHCARESummit Therapeutics PLC
AI Insight
What's Moving SMMT Today?
No stock-specific AI insight has been generated for SMMT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$12.55$30.98
$14.25
Fundamentals
Market Cap$10.8B
P/E Ratio—
EPS$-1.59
Dividend Yield—
Dividend / Share—
ROE-270.9%
Profit Margin—
Debt / Equity—
Trading
Volume6.0M
Avg Volume (10D)—
Shares Outstanding776.2M
SMMT News
28 articles- Summit Therapeutics finance chief tops list of public CFO pay in 2025Cfo·Jun 23, 2026
- Summit Therapeutics (SMMT): A $500 Million Stock Offering Pulled Just One Day After FilingYahoo Finance·Jun 22, 2026
- 5 Most Promising Healthcare Stocks According to Wall Street AnalystsInsider Monkey·Jun 21, 2026
- Summit Therapeutics (SMMT) Raises $500 Million Through Public OfferingYahoo Finance·Jun 13, 2026
- Summit Therapeutics Halts US$500m Offering After Ivonescimab Trial ResultsYahoo Finance·Jun 12, 2026
- Stocks Settle Sharply Lower on Escalating Middle East TensionsBarchart·Jun 10, 2026
- Stocks Resume Decline as Chipmakers and AI Companies FallBarchart·Jun 10, 2026
- Stocks Fall on Weakness in Tech and Trucking CompaniesBarchart·Jun 10, 2026
- Why Is SMMT Stock Tumbling Today?Stocktwits·Jun 10, 2026
- Summit Therapeutics Announces Proposed Public Offering of Common StockYahoo Finance·Jun 9, 2026
- Mizuho Strategist: Healthcare Is Now a Value Sector as Pharma Stocks Underperform Tech247 Wall St·Jun 7, 2026
- Summit Therapeutics COO, CFO & Director Acquires 1.6% More StockYahoo Finance·Jun 7, 2026
- Summit Therapeutics (SMMT) Reveals Phase II AK112-206 Trial DataYahoo Finance·Jun 5, 2026
- Summit Therapeutics to Participate in the 47th Annual Goldman Sachs Global Healthcare ConferenceYahoo Finance·Jun 4, 2026
- All You Need to Know About Summit Therapeutics (SMMT) Rating Upgrade to BuyYahoo Finance·Jun 4, 2026
- Summit (SMMT) Reports Positive Phase III Overall Survival Data for Ivonescimab in Advanced NSCLCYahoo Finance·Jun 4, 2026
- Pharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?Pharmavoice·Jun 4, 2026
- Assessing Summit Therapeutics (SMMT) Valuation After A Mixed Share Price And Long Term Return ProfileYahoo Finance·Jun 4, 2026
- ASCO26: Bispecific antibody and RET fusion-targeting assets garner attention in NSCLCPharmaceutical-technology·Jun 3, 2026
- Cantor Fitzgerald Maintains Overweight Rating on Summit Therapeutics (SMMT) Amid Mixed Clinical DevelopmentsYahoo Finance·Jun 2, 2026
- Summit Therapeutics (SMMT) Slides As Bearish Calls MountStocksToTrade·Jun 2, 2026
- Summit Therapeutics (SMMT) Sheds 10.4%, This Analyst is PessimisticYahoo Finance·Jun 2, 2026
- Why Is SMMT Stock Surging Over 10% In Overnight Trading?Stocktwits·Jun 1, 2026
- Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock RallyThe Motley Fool·May 23, 2026
- Cantor Fitzgerald reiterates Overweight on Summit Therapeutics stock By Investing.comInvesting.com Canada·May 22, 2026
- Roblox, Spotify, And Robinhood Are Among Top 10 Large-Cap Losers Last Week (April 27-May 1): Are The Others In Your Portfolio?Benzinga·May 3, 2026
- IonQ, Oklo, And Robinhood Are Among the Top 10 Large-Cap Gainers Last Week (April 13-April 17): Are the Others in Your Portfolio?Benzinga·Apr 19, 2026
- Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From NowThe Motley Fool·Mar 25, 2026
All 28 articles loaded
Price Data
Open$13.93
Previous Close$14.28
Day High$14.81
Day Low$13.93
52 Week High$30.98
52 Week Low$12.55
52-Week Range
$12.55$30.98
$14.25
Fundamentals
Market Cap$10.8B
P/E Ratio—
EPS$-1.59
Dividend Yield—
Dividend / Share—
ROE-270.9%
Profit Margin—
Debt / Equity—
Trading
Volume6.0M
Avg Volume (10D)—
Shares Outstanding776.2M
About Summit Therapeutics PLC
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and markets drugs to treat infectious diseases in the United States, Latin America, and Europe. The company is headquartered in Cambridge, Massachusetts.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—